Drugs / IL-YANG Quadrivalent Seasonal Influenza Vaccine
IL-YANG Quadrivalent Seasonal Influenza Vaccine
also known as
IL-YANG Inactivated Split Influenza Vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04381689 | Oct 2024 → May 2025 | — | Il-Yang Pharm. Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IL-YANG Quadrivalent Seasonal Influenza Vaccine | “Phase Ⅲ, Multi-national, Randomized, Double-blind, Active Controlled to Evaluate the Immunogenicity and Safety of "IL-YANG Quadrivalent Seasonal Influenza Vaccine" in Healthy...” NCT04381689 ↗ |
| Known as | IL-YANG Inactivated Split Influenza Vaccine | “The purpose of this study is to evaluate the safety and immunogenicity of IL-YANG Inactivated Split Influenza Vaccine (IL-YANG Quadrivalent Seasonal Influenza Vaccine) in...” NCT04381689 ↗ |
| Modality | Vaccine | “IL-YANG FLU Vaccine Prefilled Syringe INJ.” NCT04381689 ↗ |